Evidence map›Paper›PMID 27113448›Full record

Trial reportSubstance abuse treatment, prevention, and policy2016

Feasibility and patient satisfaction with smoking cessation interventions for prevention of healthcare-associated infections in inpatients.

Danielle M Schulte, Megan Duster, Simone Warrack, Susan Valentine, Douglas Jorenby, Daniel Shirley, James Sosman, Sheryl Catz, Nasia Safdar

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Substance abuse treatment, prevention, and policy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Interventions for smoking cessation in hospitalised patients.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Danielle M SchulteDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Megan DusterDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Simone WarrackDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Susan ValentineDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Douglas JorenbyDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Daniel ShirleyDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
James SosmanDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Sheryl CatzBetty Irene Moore School of Nursing, University of California Davis, Sacramento, CA, USA.
Nasia SafdarDepartment of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA. ns2@medicine.wisc.edu.
University of Wisconsin–Madison · USUniversity of California, Davis · USUW Health University Hospital · US

Funding

Methods CoreP50CA143188 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI FIORE, MICHAEL C · 2009 to 2013
$10.5M
Implementation of Chlorhexidine Bathing to Reduce Healthcare-Associated Infections-the Icare studyR18HS024039 · AHRQ · UNIVERSITY OF WISCONSIN-MADISON · PI SAFDAR, NASIA · 2015 to 2017
$1.5M
Barriers and Facilitators for Clostridium difficile Bundle ImplementationI21HX001490 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI SAFDAR, NASIA · 2014 to 2014
–
AHRQ HHS R18 HS024039AHRQ HHS R18HS024039HSRD VA I21 HX001490NCI NIH HHS 9P50CA143188NCI NIH HHS P50 CA143188
6 · The paper itself

Abstract

backgroundSmoking increases hospitalization and healthcare-associated infection. Our primary aim of this pilot, randomized-controlled trial was to examine the feasibility and acceptability of a tobacco cessation intervention compared with usual care in inpatients. S. aureus carriage, healthcare-associated infections and infections post discharge were exploratory outcomes.

methodsCurrent inpatient smokers from a university hospital facility were randomized to usual care or a face to face tobacco cessation counseling session where patients' tobacco use and strategies for quitting were discussed. Patient engagement, satisfaction and withdrawal symptoms were measured at 1 week and 12 weeks post discharge. Nasal swabs were collected at enrollment and discharge and assessed for S. aureus colonization. P-values were calculated using Fisher's exact and t-tests were used to compare groups.

resultsFor the study's primary outcome, participants reported the intervention as being generally acceptable and reported high overall levels of satisfaction, with a Likert scale score of at least 4/5 for all measures of satisfaction. No subjects utilized free tobacco cessation services after discharge. 83 % of the intervention group and 93 % of the control group smoked at least one cigarette after discharge. Secondary outcomes with regard to infections showed that, at discharge, 12 % of the intervention group (n = 17) and 18 % of the control group (n = 22) tested positive for S. aureus. After 3 months, 9 % of the intervention group developed infection, 41 % visited an emergency room, and 24 % were readmitted within 3 months post-discharge, compared to 27, 32 and 36 % of the control group respectively.

conclusionsWith regards to the primary aim of this study, there were overall high levels of satisfaction with the intervention, indicating good feasibility and acceptance among patients. However, more intensive interventions in hospitalized patients and impact on healthcare-associated infections and post-discharge infections should be explored.

Indexed as

Patient SatisfactionAdultCross InfectionFeasibility StudiesFemaleHumansInpatientsMaleMiddle AgedNosePilot ProjectsSmoking CessationStaphylococcal InfectionsSubstance Withdrawal SyndromeWisconsinHealthcare-associated infectionsInfection controlMRSAStaphylococcus aureusTobacco cessation

Identifiers

PMID27113448
PMCPMC4845502
OpenAlexW2343744561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.